Table 2.
Summary of the Descriptive Characteristics of Selected Population (MBSAQIP, 2015–2018), by Immunosuppressant Use
| Variable | Total (n = 442258) | Immunosuppressant use + (n = 7987) | Immunosuppressant use − (n = 434271) | p Value* |
|---|---|---|---|---|
| Age | <0.0001† | |||
| <30 y | 52914 (11.96) | 445 (5.57) | 52469 (12.08) | |
| 31–60 y | 343122 (77.58) | 6375 (79.82) | 4336747 (77.54) | |
| >60 y | 46222 (10.45) | 1167 (14.61) | 45055 (10.37) | |
| Sex | <0.0001† | |||
| Female | 353867 (80.01) | 6666 (83.46) | 347201 (79.95) | |
| Male | 88391 (19.99) | 1321 (16.54) | 87070 (20.05) | |
| Ethnicity | 0.0003† | |||
| Hispanic | 43060 (9.74) | 749 (9.38) | 42311 (9.74) | |
| NHW | 257963 (58.33) | 4667 (58.43) | 253296 (58.33) | |
| NHB | 74730 (16.90) | 1466 (18.35) | 73264 (16.87) | |
| Other | 66505 (15.04) | 1105 (13.83) | 65400 (15.06) | |
| BMI | 0.0046† | |||
| <35 kg/m2 | 23619 (5.34) | 426 (5.33) | 23193 (5.34) | |
| 35–39 kg/m2 | 82838 (18.73) | 1618 (20.26) | 81220 (18.70) | |
| 40–49 kg/m2 | 231038 (52.24) | 4066 (50.91) | 226972 (52.27) | |
| ≥50 kg/m2 | 104763 (23.69) | 1877 (23.50) | 102886 (23.69) | |
| Operation type | 0.0011† | |||
| LSG | 322131 (72.84) | 5946 (74.45) | 316185 (72.81) | |
| LRYGB | 120127 (27.16) | 2041 (25.55) | 118086 (27.16) | |
| Preoperative diabetes | <0.0001† | |||
| Yes | 113174 (25.59) | 2377 (29.76) | 110797 (25.51) | |
| No | 329084 (74.41) | 5610 (70.24) | 323474 (74.49) |
Data presented as n (%)
*
Chi-square test
†
Statistically significant
LRYGB, laparoscopic Roux-en-Y gastric bypass; LSG, laparoscopic sleeve gastrectomy; NHB, Non-Hispanic black; NHW, Non-Hispanic white